Furthermore, our results suggested that IMP3-promoted cell migration could be inhibited by NF-κB pathway inhibitor, indicating that IMP3 promoting RCC cell migration requires activation of NF-κB pathway, which represents a novel mechanism accounting for IMP3 regulation of cancer progression. The gene discussed is IMP3; the disease is renal cell carcinoma.